#ILT2 - Twitter Hashtag

BuzzFeed Cricket @Buzzfeedcricket

over 1 year ago

Fakhar Zaman is turning the game on single handedly 🥶🥶🥶 #ILT2

0

2

1

0

19

Spontonic @spontonic

almost 2 years ago

anti-#ILT2.... results from this trial being presented at ESMO24. Dose escalation results.... "Partial responses were observed in Part 1A (1/31), Part 1B (1/23) and Part 1C (2/22) pts". Search NCT04717375 https://t.co/tEmazgqyEK

1

3

0

1

281

GR Malik 🇵🇰 @Arainshahzada20

over 2 years ago

Mohammad Amir bowled well for the Desert Vipers, picking up 3/26 in his 4 overs! #ILT2

0

2

1

0

63

Bertrand Delsuc @BertrandBio

about 4 years ago

Merck $MRK to Hold Investor Event to Highlight Oncology Portfolio and Pipeline #TIGIT #ILT4 #ILT2 #IL2 #ROR1 #CellRx (!!!) #HIF2a #KRASG12C https://t.co/kKRFg4ja8a

BertrandBio's tweet photo. Merck $MRK to Hold Investor Event to Highlight Oncology Portfolio and Pipeline #TIGIT #ILT4 #ILT2 #IL2 #ROR1 #CellRx (!!!) #HIF2a #KRASG12C https://t.co/kKRFg4ja8a https://t.co/BdwUmnyAoe

2

9

3

2

0

Cancer Immunology Research @CIR_AACR

over 6 years ago

ICYMI: Read about an effector T-cell subset lacking #PD1 expression that has potential as a therapeutic target #ILT2 #RenalCellCarcinoma #CheckpointBlockade https://t.co/F0eVNxpY5z

CIR_AACR's tweet photo. ICYMI: Read about an effector T-cell subset lacking #PD1 expression that has potential as a therapeutic target #ILT2
#RenalCellCarcinoma #CheckpointBlockade https://t.co/F0eVNxpY5z https://t.co/bgGODQsO5C

0

2

1

0

Cancer Immunology Research @CIR_AACR

over 6 years ago

Read about an effector T-cell subset lacking #PD1 expression that has potential as a therapeutic target. #ILT2 #RenalCellCarcinoma #CheckpointBlockade https://t.co/Hsclzlw5pJ

CIR_AACR's tweet photo. Read about an effector T-cell subset lacking #PD1 expression that has potential as a therapeutic target. #ILT2 #RenalCellCarcinoma
#CheckpointBlockade https://t.co/Hsclzlw5pJ https://t.co/latGt85PQs

0

1

0

Cancer Immunology Research @CIR_AACR

almost 7 years ago

Read about an effector T-cell subset lacking #PD1 expression that has potential as a therapeutic target #ILT2 #RenalCellCarcinoma #CheckpointBlockade https://t.co/wqFJgGS7FM

0

2

0

Daniel Marsden 💙 @dmarsden49

over 7 years ago · Kingston upon Thames

Valuable time to explore the #DEFT toolkit with author @DocWinstone - primary learning - assessment comments are not feedback! Feedback is the process of internalisation & learning from comments. #ILT2

1

3

0